Major heart study aims to Fine-Tune Blood-Thinner use for safer recovery
NCT ID NCT07354828
Summary
This study aims to understand and improve the real-world use of dual blood-thinning therapy (DAPT) in patients who have had a heart attack and received a stent. It will follow 3,500 patients at high risk for bleeding for one year to see how their treatment is managed and to test a new scoring system designed to predict their risk of future heart problems. The goal is to gather evidence to create better, more personalized national standards for care after these procedures.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CORONARY ARTERY DISEASE (CAD) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
General Hospital of Northern Theater Command
Shenyang, Liaoning, 110000, China
Conditions
Explore the condition pages connected to this study.